文献速递头颈外科

5-氨基酮戊酸荧光引导手术治疗头颈部鳞状细胞癌

5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma.
PubMed 文献 · Laryngoscope · 2023-08-04

这项前瞻性先导试验在7例头颈部鳞状细胞癌患者切除术前3-5小时口服5-氨基酮戊酸(5-ALA),术中405nm蓝光下所有标本均显示强荧光,荧光可预测神经周围侵犯、切缘阳性和转移性淋巴结;2例出现急性光敏反应,1例出现肝酶一过性升高。

要点

  • 术前3-5小时口服5-ALA,术中405nm蓝光下所有头颈鳞癌标本均显示强荧光。
  • 5-ALA荧光可预测神经周围侵犯、切缘阳性和转移性淋巴结。
  • 2例出现急性光敏反应,1例出现肝酶一过性升高。

核心结论

  • 5-ALA可诱导头颈鳞癌术中强荧光,能够显示切缘阳性、神经周围侵犯和转移性淋巴结病变。
  • 作者指出本研究未就5-ALA在头颈癌人群中的安全性得出结论,但研究结果与神经外科文献中广泛的安全性数据一致。
  • 未来应用可能包括术中切缘状态评估、诊断准确性和对生存的影响。

研究设计与样本

  • 前瞻性先导试验,共7例头颈部鳞状细胞癌患者接受5-ALA引导下肿瘤切除术。
  • 5-ALA以口服混悬液形式在麻醉诱导前3-5小时给药,切除后应用405nm蓝光并记录肿瘤及手术床荧光。
  • 标本荧光强度由术者术中分级为无(评分=0)、轻度(1)、中度(2)或强(3),并与最终病理诊断相互印证。

主要发现

  • 7例患者中5例(83%)为男性,年龄范围33-82岁(平均60岁)。
  • 肿瘤部位包括鼻腔(n=3)、口腔(n=3)和喉(n=1)。
  • 所有标本在术前3-5小时给予5-ALA后均显示强荧光。
  • 5-ALA荧光预测了神经周围侵犯、切缘阳性和转移性淋巴结病变的存在。
  • 2例患者出现急性光敏反应,1例患者出现肝酶一过性升高。

局限性

  • 作者指出本研究未就5-ALA在头颈癌人群中的安全性得出结论。
  • 证据水平为4。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the utility of 5-aminolevulinic acid (5-ALA) fluorescence for resection of head and neck carcinoma. METHODS: In this prospective pilot trial, 5-ALA was administered as an oral suspension 3-5 h prior to induction of anesthesia for resection of head and neck squamous cell carcinoma (HNSCC). Following resection, 405 nm blue light was applied, and fluorescence of the tumor as well as the surgical bed was recorded. Specimen fluorescence intensity was graded categorically as none (score = 0), mild (1), moderate (2), or robust (3) by the operating surgeon intraoperatively and corroborated with final pathologic diagnosis. RESULTS: Seven patients underwent resection with 5-ALA. Five (83%) were male with an age range of 33-82 years (mean = 60). Sites included nasal cavity (n = 3), oral cavity (n = 3), and the larynx (n = 1). All specimens demonstrated robust fluorescence when 5-ALA was administered 3-5 h preoperatively. 5-ALA fluorescence predicted the presence of perineural invasion, a positive margin, and metastatic lymphadenopathy. Two patients had acute photosensitivity reactions, and one patient had a temporary elevation of hepatic enzymes. CONCLUSIONS: 5-ALA induces robust intraoperative fluorescence of HNSCC, capable of demonstrating a positive margin, perineural invasion, and metastatic nodal disease. Although no conclusions are there about the safety of this drug in the head and neck cancer population, our study parallels the extensive safety data in the neurosurgical literature. Future applications may include intraoperative assessment of margin status, diagnostic accuracy, and impacts on survival. LEVEL OF EVIDENCE: 4 Laryngoscope, 134:741-748, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Filip P, Lerner DK, Kominsky E, et al. 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma. Laryngoscope. 2023. PMID: 37540051. doi:10.1002/lary.30910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。